26,50 €
2,22 % gestern
L&S, 30. Oktober, 22:54 Uhr
ISIN
IE00B56GVS15
Symbol
ALKS
Berichte

Alkermes Plc Aktie News

Neutral
Seeking Alpha
2 Tage alt
Alkermes plc (NASDAQ:ALKS ) Q3 2025 Earnings Call October 28, 2025 8:00 AM EDT Company Participants Sandra Coombs - Senior Vice President of Corporate Affairs & Investor Relations Richard F. Pops - Chairman & CEO Joshua Reed - Chief Financial Officer C.
Neutral
PRNewsWire
3 Tage alt
—    Third Quarter Revenues of $394.2 Million — —    GAAP Net Income of $82.8 Million and Diluted GAAP Earnings per Share of $0.49 — —    Company Raises 2025 Financial Expectations — DUBLIN , Oct. 28, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving strong revenue growth and...
Neutral
Business Wire
8 Tage alt
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avadel Pharmaceuticals plc (NasdaqGM: AVDL) to Alkermes plc (NasdaqGS: ALKS). Under the terms of the proposed transaction, shareholders of Avadel will receive $18.50 per share, plus a non-transfera...
Neutral
Seeking Alpha
8 Tage alt
Alkermes plc (NASDAQ:ALKS ) M&A Call October 22, 2025 8:00 AM EDT Company Participants Sandra Coombs - Senior Vice President of Corporate Affairs & Investor Relations Richard F. Pops - Chairman & CEO Joshua Reed - Chief Financial Officer Blair Jackson - Executive VP, Chief Risk Officer & COO Conference Call Participants Leonid Timashev - RBC Capital Markets, Research Division Paul Matteis - Sti...
Neutral
Investors Business Daily
8 Tage alt
Shares of Alkermes and Avadel Pharmaceuticals diverged Wednesday after the former agreed to buy the latter for up to $2.1 billion.
Positiv
Reuters
9 Tage alt
Alkermes said on Wednesday it will acquire Avadel Pharmaceuticals for up to $2.1 billion gaining access to the company's approved excessive daytime sleepiness drug.
Neutral
PRNewsWire
9 Tage alt
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.7 OF THE IRISH TAKEOVER RULES   —     Augments Revenue Growth Profile and Diversifies Alkermes' Commercial Portfolio with New High Growth Produc...
Neutral
PRNewsWire
10 Tage alt
DUBLIN , Oct. 20, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (12:00 p.m.

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen